哮喘
医学
清晰
儿科
喘息
重症监护医学
免疫学
生物化学
化学
作者
Leonard B. Bacharier,Theresa W. Guilbert,Tuomas Jartti,Sejal Saglani
标识
DOI:10.1016/j.jaip.2021.02.045
摘要
Wheezing disorders in children younger than 5 years are common, but lack of clarity remains about which children should be treated to prevent symptoms and acute episodes. The aim of this review was to discuss a practical approach to deciding which children younger than 5 years with asthma should be treated, and if so, with which strategy. The importance of having a clear definition of “asthma” for this age group, determined by a collection of presenting respiratory symptoms, without assumptions about underlying mechanisms is addressed. Subsequent consideration should be given to timing, severity, and frequency of symptoms, together with assessment of objective biomarkers, including aeroallergen sensitization and blood eosinophils, to inform whether or not a preschooler with recurrent wheezing requires treatment. Numerous unanswered questions remain about the optimal management of nonallergic preschool wheezing and asthma, and areas of specific unmet need and future directions for research are highlighted.
科研通智能强力驱动
Strongly Powered by AbleSci AI